Celgene options rights to Abide's serine hydrolase program; could acquire the company; deal terminated
Drug Discovery Tools
- Molecular Diversity
- Drug Discovery Tools
- Intra-Biotech Deal
- Includes M&A Option
- Includes Equity
- R+D and Marketing-Licensing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.